Duhmel et al. reported that MDM2 could be utilized to distinguish parosteal osteosarcoma from conventional osteosarcoma, as 85% of parosteal osteosarcomas in their sample were MDM2 amplification positive [4]. The gene discussed is MDM2; the disease is osteosarcoma.